1. Home
  2. MACI vs TSVT Comparison

MACI vs TSVT Comparison

Compare MACI & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MACI
  • TSVT
  • Stock Information
  • Founded
  • MACI 2024
  • TSVT 2021
  • Country
  • MACI United States
  • TSVT United States
  • Employees
  • MACI N/A
  • TSVT N/A
  • Industry
  • MACI
  • TSVT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MACI
  • TSVT Health Care
  • Exchange
  • MACI NYSE
  • TSVT Nasdaq
  • Market Cap
  • MACI 221.6M
  • TSVT 258.9M
  • IPO Year
  • MACI 2024
  • TSVT N/A
  • Fundamental
  • Price
  • MACI $10.32
  • TSVT $4.99
  • Analyst Decision
  • MACI
  • TSVT Buy
  • Analyst Count
  • MACI 0
  • TSVT 4
  • Target Price
  • MACI N/A
  • TSVT $6.50
  • AVG Volume (30 Days)
  • MACI 9.3K
  • TSVT 726.2K
  • Earning Date
  • MACI 01-01-0001
  • TSVT 05-07-2025
  • Dividend Yield
  • MACI N/A
  • TSVT N/A
  • EPS Growth
  • MACI N/A
  • TSVT N/A
  • EPS
  • MACI N/A
  • TSVT N/A
  • Revenue
  • MACI N/A
  • TSVT $48,365,000.00
  • Revenue This Year
  • MACI N/A
  • TSVT $84.48
  • Revenue Next Year
  • MACI N/A
  • TSVT $9.69
  • P/E Ratio
  • MACI $44.17
  • TSVT N/A
  • Revenue Growth
  • MACI N/A
  • TSVT N/A
  • 52 Week Low
  • MACI $9.95
  • TSVT $2.29
  • 52 Week High
  • MACI $10.35
  • TSVT $5.30
  • Technical
  • Relative Strength Index (RSI)
  • MACI N/A
  • TSVT 71.10
  • Support Level
  • MACI N/A
  • TSVT $4.97
  • Resistance Level
  • MACI N/A
  • TSVT $4.99
  • Average True Range (ATR)
  • MACI 0.00
  • TSVT 0.01
  • MACD
  • MACI 0.00
  • TSVT -0.04
  • Stochastic Oscillator
  • MACI 0.00
  • TSVT 50.00

About MACI MELAR ACQUISITION CORP. I

Melar Acquisition Corp I is a blank check company.

About TSVT 2seventy bio Inc.

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

Share on Social Networks: